The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jun. 16, 2020
Filed:
Dec. 03, 2015
Applicant:
Mor Research Applications Ltd., Tel Aviv, IL;
Inventors:
Zeev Dvashi, Tel Aviv, IL;
Ayala Pollack, Tel Aviv, IL;
Assignee:
MOR RESEARCH APPLICATIONS LTD., Tel Aviv, IL;
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/223 (2006.01); A61K 31/40 (2006.01); A61K 9/00 (2006.01); A61K 45/06 (2006.01); A61K 38/05 (2006.01); A61P 25/28 (2006.01); A61P 27/02 (2006.01);
U.S. Cl.
CPC ...
A61K 31/223 (2013.01); A61K 9/0019 (2013.01); A61K 9/0048 (2013.01); A61K 9/0051 (2013.01); A61K 31/40 (2013.01); A61K 38/05 (2013.01); A61K 45/06 (2013.01); A61P 25/28 (2018.01); A61P 27/02 (2018.01);
Abstract
This disclosure relates to compositions for use in treatment of Alzheimer's Disease, and/or a ocular and retinal degenerative disease, such as age related macular degeneration. The described compositions include effective amounts of LLMe, the hydrobromide form thereof, or functional derivatives thereof. Methods of treatment of a retinal degenerative disease of Alzheimer's Disease using the described compositions are also provided.